Download PDF
CC BY 4.0 · Indian J Plast Surg
DOI: 10.1055/s-0045-1809150
Original Article

Eyelash Rejuvenation Using Bimatoprost 0.03%: A Prospective Pilot Split-Face Study in Indian Population

Manoj Kumar Johar
1   Department of Aesthetic, Reconstructive and Plastic Surgery, Max Super Speciality Hospital, Delhi, India
,
Digjeet Kaur
1   Department of Aesthetic, Reconstructive and Plastic Surgery, Max Super Speciality Hospital, Delhi, India
,
Pradeep Singh
1   Department of Aesthetic, Reconstructive and Plastic Surgery, Max Super Speciality Hospital, Delhi, India
,
Ankur Bhatia
1   Department of Aesthetic, Reconstructive and Plastic Surgery, Max Super Speciality Hospital, Delhi, India
,
Nishant Kumar
1   Department of Aesthetic, Reconstructive and Plastic Surgery, Max Super Speciality Hospital, Delhi, India
› Author Affiliations
› Further Information
Also available at
   Permissions and Reprints

Abstract

Background

Ophthalmic bimatoprost has been used worldwide for treatment of glaucoma, and enhanced eyelash growth has been reported with such use. Dermal application of prevalent bimatoprost preparations for eyelash enhancement has been reported with adverse effects.

Objective

This article assesses if revised formulation (Trulush) of bimatoprost 0.03% provides effective as well as safe eyelash enhancement in Indian population.

Materials and Methods

Prospective split-face study was conducted for 12 weeks in willing subjects for their eyelash rejuvenation. Subjects completed the pre- and post-study questionnaires for subjective evaluation. Bimatoprost (Trulush) was applied on the upper eyelid margin once a day. Adverse events were also assessed. Objective evaluation was done using available digital scale and pre- and post-study photographs at 12 weeks.

Results

All Subjects reported improvement in length, darkness, and density. Objective assessment corresponded with the subjective assessments. No significant adverse effects were reported by the subjects.

Conclusion

Bimatoprost 0.03%, in the available formulation (Trulush), is found to be effective for topical application and eyelash rejuvenation by their increase in length, darkness, and density. There are no significant side effects.

Keywords

eyelash rejuvenation - prostaglandin - Trulush - bimatoprost


Publication History

Article published online:
19 May 2025

© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Yoelin S, Walt JG, Earl M. Safety, effectiveness, and subjective experience with topical bimatoprost 0.03% for eyelash growth. Dermatol Surg 2010; 36 (05) 638-649
    PubMedSearch in Google Scholar
  • 2 Wirta D, Pariser DM, Yoelin SG. et al. Bimatoprost 0.03% for the treatment of eyelash hypotrichosis: a pooled safety analysis of six randomized, double-masked clinical trials. J Clin Aesthet Dermatol 2015; 8 (07) 17-29
    PubMedSearch in Google Scholar
  • 3 Easthope SE, Perry CM. Topical bimatoprost: a review of its use in open-angle glaucoma and ocular hypertension. Drugs Aging 2002; 19 (03) 231-248
    PubMedSearch in Google Scholar
  • 4 Woodward JA, Haggerty CJ, Stinnett SS, Williams ZY. Bimatoprost 0.03% gel for cosmetic eyelash growth and enhancement. J Cosmet Dermatol 2010; 9 (02) 96-102
    PubMedSearch in Google Scholar
  • 5 Dang J, Cole JC, Burgess SM, Yang M, Daniels SR, Walt JG. Development and validation of the eyelash satisfaction questionnaire. Aesthet Surg J 2016; 36 (02) 221-228
    PubMedSearch in Google Scholar
  • 6 Smith S, Fagien S, Whitcup SM. et al. Eyelash growth in subjects treated with bimatoprost: a multicenter, randomized, double-masked, vehicle-controlled, parallel-group study. J Am Acad Dermatol 2012; 66 (05) 801-806
    PubMedSearch in Google Scholar
  • 7 Johnstone MA. Hypertrichosis and increased pigmentation of eyelashes and adjacent hair in the region of the ipsilateral eyelids of patients treated with unilateral topical latanoprost. Am J Ophthalmol 1997; 124 (04) 544-547
    PubMedSearch in Google Scholar
  • 8 Harii K, Arase S, Tsuboi R, Weng E, Daniels S, VanDenburgh A. Bimatoprost for eyelash growth in Japanese subjects: two multicenter controlled studies. [published correction appears in Aesthetic Plast Surg. 2014 Oct;38(5):1071–2] Aesthetic Plast Surg 2014; 38 (02) 451-460
    PubMedSearch in Google Scholar
  • 9 Wester ST, Lee WW, Shi W. Eyelash growth from application of bimatoprost in gel suspension to the base of the eyelashes. Ophthalmology 2010; 117 (05) 1024-1031
    PubMedSearch in Google Scholar